New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2012
14:32 EDTCSCO, MON, GS, INTC, CVX, T, JPM, PFE, EXC, MSFT, ZION, RF, FITB, WFC, CNeuberger's value hunter Salzmann likes Citigroup and Microsoft, Barron's says
Barron's profiled Neuberger Berman's new large-cap value specialist Eli Salzmann who was recruited 13 months ago to restore the firms' historically strong large-cap value franchise. Salzmann is a traditional value manager who aims to beat the Russell 1000 Value Index over the next few years. He searches for companies that have depressed earnings relative to their true mid-economic-cycle earnings. Some of his favorites are U.S. banks, many of which are trading below tangible book value despite a recent surge in the sector. Salzmann started buying banks late last year as they began to benefit from the troubles in Europe. He likes Citigroup ( C ) and Wells Fargo (WFC) -- and has been buying shares of big regional banks, such as Fifth Third Bank (FITB), Regions Financial (RF) and Zions Bancorp (ZION). Salzmann is also bullish on large tech stocks, which are trading at about 10x earnings, have strong balance sheets and could benefit as capital spending increases. A favorite is Microsoft (MSFT). Salzmann expects the stock to see $40 over the next 12 - 24 months. One last pick: though he's generally negative on utilities, Salzmann like Exelon Generation (EXC). Other holdings: PFE, JPM, T, CVX, INTC, GS, MON and CSCO. Reference Link
News For C;WFC;FITB;RF;ZION;MSFT;EXC;PFE;JPM;T;CVX;INTC;GS;MON;CSCO From The Last 14 Days
Check below for free stories on C;WFC;FITB;RF;ZION;MSFT;EXC;PFE;JPM;T;CVX;INTC;GS;MON;CSCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
August 19, 2014
09:02 EDTEXCExelon, Pepco file for merger approval with Maryland Public Service Commission
Subscribe for More Information
08:42 EDTCSCOImperva new CEO has history of selling companies, says Sterne Agee
After Imperva (IMPV) appointed Anthony Bettencourt as its new CEO, Sterne Agee says that he has a history of selling companies. The firm believes that Imperva "would likely be an acquisition candidate" for a number of large tech companies such as Cisco (CSC), Juniper (JNPR), HP (HPQ), IBM (IBM), Check Point (CHKP), or F5 (FFIV). Sterne Agee believes that Imperva could be acquired for as much as $45 per share, and it keeps a Buy rating on the stock.
07:47 EDTEXCExelon management to meet with SunTrust
Subscribe for More Information
07:12 EDTTFCC looks into telecom special access line rates, Reuters says
Subscribe for More Information
06:46 EDTTAT&T technology routes calls to multiple devices, Re/code says
AT&T has developed technology that sends calls from one device to many other devices, Re/code reported yesterday. Reference Link
06:34 EDTGSGoldman abandons effort to toss out $1B Gaddafi suit, Telegraph says
Goldman Sachs (GS) abandoned its effort to toss out a London court suit from the Libyan Investment Authority who alleged that the bank lost over $1B worth of funds during the final years of Muammar Gaddafi's reign as dictator, according to the Telegraph, citing comments from the LIA. The LIA sued both Goldman and Societe Generale (SCGLY) over claims that the banks' London divisions took-in exorbitant fees while losing money in derivative trades. Reference Link
August 18, 2014
18:33 EDTTSprint introduces Sprint Family Share Pack data plan, doubles high-speed data
Subscribe for More Information
16:00 EDTCOptions Update; August 18, 2014
Subscribe for More Information
13:12 EDTMSFTMicrosoft getting ready to launch Chromebook challengers, 9to5Google says
Subscribe for More Information
11:41 EDTPFECubist rises after report sparks takeover interest speculation
Subscribe for More Information
10:32 EDTGSProcter & Gamble likely to divest Duracell, Braun, Reuters reports
Subscribe for More Information
10:29 EDTINTCGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
09:35 EDTC, WFCActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN DG TSLA GILD FB ABX WFC C
09:20 EDTGSDeutsche Bank appoints Shannon Americas Chief Information Officer
Subscribe for More Information
08:47 EDTTRaymond James to hold a summit
Subscribe for More Information
08:04 EDTINTCSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.
08:01 EDTPFEPfizer announces submission of Palbociclib NDA to FDA
Pfizer announced it has completed the submission of a New Drug Application to the United States Food and Drug Administration for palbociclib. This NDA requests FDA approval of palbociclib, in combination with letrozole, for the treatment of postmenopausal women with estrogen receptor positive, human epidermal growth factor receptor 2 negative advanced breast cancer who have not received previous systemic treatment for their advanced disease. The submission is based on the final results of PALOMA-1, a randomized, Phase 2 trial comparing palbociclib plus letrozole versus letrozole alone in this population of patients. Palbociclib received Breakthrough Therapy designation from the FDA in April 2013, for the first-line systemic treatment of women with advanced or metastatic ER+, HER2- breast cancer. This designation was based on interim data from the PALOMA-1 trial. The FDA has a 60-day filing review period to determine whether the NDA is complete and acceptable for filing. Pfizer will communicate the Agency’s decision.
07:57 EDTPFECambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
06:47 EDTCU.S. banks consider Ireland fitting spot for EU divisions, FT says
Subscribe for More Information
August 17, 2014
16:34 EDTGSMick Davis in talks to buy Colombia's CNR from Goldman, Sunday Times says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use